Sika Interplant Systems Limited carries a market capitalization of 24.89B, placing it among publicly traded companies globally. Its enterprise value stands at 16.81B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 24.89B |
| Enterprise Value | 16.81B |
Sika Interplant Systems Limited currently has 21.20M shares outstanding.
| Shares Outstanding | 21.20M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Sika Interplant Systems Limited trades at a trailing price-to-earnings ratio of 46.68. The price-to-sales ratio is 8.09, and the price-to-book ratio stands at 403.02.
| PE Ratio | 46.68 |
| PS Ratio | 8.09 |
| PB Ratio | 403.02 |
| P/TBV Ratio | 11.03 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Sika Interplant Systems Limited trades at an EV/EBITDA multiple of 38.12 and an EV/FCF ratio of 4,416.06. The EV/Sales ratio of 7.96 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 38.12 provides insight into valuation relative to core operating earnings.
| EV / Sales | 7.96 |
| EV / EBITDA | 38.12 |
| EV / EBIT | 38.12 |
| EV / FCF | 4,416.06 |
Sika Interplant Systems Limited maintains a current ratio of 3.42, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.42 |
| Quick Ratio | 1.91 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | 87.02 |
Sika Interplant Systems Limited posts a return on equity of 70.51 and a return on invested capital of 23.70.
| Return on Equity (ROE) | 70.51 |
| Return on Assets (ROA) | 22.34 |
| Return on Invested Capital (ROIC) | 23.70 |
| Return on Capital Employed (ROCE) | 71.24 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 32.08 |
Over the trailing twelve months, Sika Interplant Systems Limited has paid 121.22M in income taxes, reflecting an effective tax rate of 24.88.
| Income Tax | 121.22M |
| Effective Tax Rate | 24.88 |
Sika Interplant Systems Limited's stock has declined approximately -15.30277% over the past 52 weeks. The 50-day moving average sits at 989.12, while the 200-day moving average is 998.69.
| Beta (5Y) | N/A |
| 52-Week Price Change | -15.30277% |
| 50-Day Moving Average | 989.12 |
| 200-Day Moving Average | 998.69 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Sika Interplant Systems Limited generated 2.11B in revenue and converted that into 366.07M in net income, yielding earnings per share of 17.27. EBITDA reached 441.04M, while operating income came in at 441.04M.
| Revenue | 2.11B |
| Gross Profit | 646.33M |
| Operating Income | 441.04M |
| Pretax Income | 487.29M |
| Net Income | 366.07M |
| EBITDA | 441.04M |
| EBIT | 441.04M |
| Earnings Per Share (EPS) | 17.27 |
Total book value stands at 42.40M, with working capital of 348.89M providing operational flexibility.
| Cash & Cash Equivalents | 275.78M |
| Total Debt | N/A |
| Net Debt | -26.17M |
| Equity (Book Value) | 42.40M |
| Book Value Per Share | 2.00 |
| Working Capital | 348.89M |
Sika Interplant Systems Limited operates with a gross margin of 30.60, reflecting its pricing power and cost economics. The operating margin of 20.88 and net profit margin of 17.33 provide insight into operational efficiency.
| Gross Margin | 30.60 |
| Operating Margin | 20.88 |
| Pretax Margin | 23.07 |
| Profit Margin | 17.33 |
| EBITDA Margin | 20.88 |
Sika Interplant Systems Limited's most recent stock split took place on March 17, 2025 with a 1:5 split ratio.
| Last Split Date | 3/17/2025 |
| Split Ratio | 1:5 |
Sika Interplant Systems Limited posts an Altman Z-Score of 54.56, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 54.56 |